Human BTLA Protein (BTL-HM201)
Human BTLA Protein (BTL-HM201)
Human BTLA Protein (BTL-HM201)
Human BTLA Protein (BTL-HM201)
  • Express System: HEK293
  • Product Tag: C-hFc
  • Purity: > 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
  • Activity: Immobilized Human HVEM, His Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Human BTLA, hFc Tag with the EC50 of 7.2ng/ml determined by ELISA (QC Test). See testing image for detail.
  • Amino Acid Range: Lys31-Ser150
Catalog #BTL-HM201
Regular price $264.00
/
Size

Order now, ships by:

Product Description
Recombinant Human BTLA Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Lys31-Ser150.
Product Background
B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2. BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14.
Product Category
Recombinant Protein / Antibody discovery / Immune checkpoint proteins
Protein
BTLA
Synonyms
CD272; BTLA; BTLA1; FLJ16065; MGC129743
Accession
Species
Human
Biotinylated
no
Amino Acid Range
Lys31-Ser150
Molecular Weight
The protein has a predicted MW of 40.5 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Human HVEM, His Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Human BTLA, hFc Tag with the EC50 of 7.2ng/ml determined by ELISA (QC Test). See testing image for detail.

Product Tag

C-hFc
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE;> 95% as determined by HPLC
Endotoxin
Less than 1 EU per ug by the LAL method.
Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 12 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Human HVEM, His Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Human BTLA, hFc Tag with the EC50 of 7.2ng/ml determined by ELISA (QC Test). Immobilized Human HVEM, His Tag at 2ug/ml (100ul/Well) on the plate. Dose response curve for Human BTLA, hFc Tag with the EC50 of 7.2ng/ml determined by ELISA (QC Test).
Immobilized Human BTLA, hFc Tag at 0.2ug/ml (100ul/Well) on the plate. Dose response curve for Biotinylated Anti-BTLA Antibody, hFc Tag with the EC50 of 11.4ng/ml determined by ELISA. Immobilized Human BTLA, hFc Tag at 0.2ug/ml (100ul/Well) on the plate. Dose response curve for Biotinylated Anti-BTLA Antibody, hFc Tag with the EC50 of 11.4ng/ml determined by ELISA.
Human BTLA-on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Human BTLA-on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
The purity of Human BTLA is greater than 95% as determined by SEC-HPLC. The purity of Human BTLA is greater than 95% as determined by SEC-HPLC.
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recently viewed